Temsirolimus Clinical Trials
6 recruitingDrug
Phase 22Early Phase 12Not Applicable1Phase 31
Showing 1–6 of 6 trials
Recruiting
Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Advanced Solid TumorsMultiple MyelomaLymphoma, Non-Hodgkin
American Society of Clinical Oncology4,200 enrolled174 locationsNCT02693535
Recruiting
Phase 2
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
Advanced Solid TumorsMultiple MyelomaLymphoma, Non-Hodgkin
Canadian Cancer Trials Group720 enrolled10 locationsNCT03297606
Recruiting
Not Applicable
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
Metastatic SarcomaResectable SarcomaRecurrent Sarcoma
M.D. Anderson Cancer Center20 enrolled1 locationNCT04199026
Recruiting
Phase 3
Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
Peripheral Artery DiseaseCritical Limb Ischemia
Mercator MedSystems, Inc.250 enrolled2 locationsNCT04433572
Recruiting
Early Phase 1
Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
GlioblastomaGliomaGlioma, Malignant+1 more
Nader Sanai12 enrolled1 locationNCT05773326
Recruiting
Early Phase 1
Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence
Solid Tumor
Miller Children's & Women's Hospital Long Beach20 enrolled2 locationsNCT02446431